Nuformix uses cocrystal technology to re-engineer the crystalline form of drugs. A selected drug is crystallised together with pharmaceutically acceptable inactive ingredients, yielding multi-component crystalline drug substances.
The vast majority of drug substances possess physical properties that are far from ideal for development as a medicine. Consequently, drug products frequently perform sub-optimally and are not always best suited to the needs of the patient or the disease.
The novel drug cocrystals created have new and improved physical properties that can enable advantageous new products and strategic benefits.